Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats

We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular and cellular cardiology Vol. 51; no. 2; pp. 144 - 155
Main Authors Chemaly, Elie R., Hadri, Lahouaria, Zhang, Shihong, Kim, Maengjo, Kohlbrenner, Erik, Sheng, Jipo, Liang, Lifan, Chen, Jiqiu, K-Raman, Purushothaman, Hajjar, Roger J., Lebeche, Djamel
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.08.2011
Subjects
Online AccessGet full text
ISSN0022-2828
1095-8584
1095-8584
DOI10.1016/j.yjmcc.2011.04.006

Cover

Abstract We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial". ► The long-term in vivo cardiovascular effects of resistin are investigated using AAV9. ► Resistin overexpression in the myocardium induced systolic dysfunction. ► Molecular markers of stress and hypertrophy are increased by resistin in vivo. ► Resistin overexpression induced oxidative stress, myocardial fibrosis and apoptosis. ► Resistin-induced oxidative stress may underlie mechanism governing cardiac remodeling.
AbstractList Abstract We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo , along with an apoptotic molecular phenotype in vivo and in vitro . Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial".
We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial". ► The long-term in vivo cardiovascular effects of resistin are investigated using AAV9. ► Resistin overexpression in the myocardium induced systolic dysfunction. ► Molecular markers of stress and hypertrophy are increased by resistin in vivo. ► Resistin overexpression induced oxidative stress, myocardial fibrosis and apoptosis. ► Resistin-induced oxidative stress may underlie mechanism governing cardiac remodeling.
We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial".
We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy.
We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial".We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial".
Author Chemaly, Elie R.
Lebeche, Djamel
Sheng, Jipo
Kim, Maengjo
Hajjar, Roger J.
Zhang, Shihong
Liang, Lifan
Hadri, Lahouaria
Kohlbrenner, Erik
Chen, Jiqiu
K-Raman, Purushothaman
Author_xml – sequence: 1
  givenname: Elie R.
  surname: Chemaly
  fullname: Chemaly, Elie R.
– sequence: 2
  givenname: Lahouaria
  surname: Hadri
  fullname: Hadri, Lahouaria
– sequence: 3
  givenname: Shihong
  surname: Zhang
  fullname: Zhang, Shihong
– sequence: 4
  givenname: Maengjo
  surname: Kim
  fullname: Kim, Maengjo
– sequence: 5
  givenname: Erik
  surname: Kohlbrenner
  fullname: Kohlbrenner, Erik
– sequence: 6
  givenname: Jipo
  surname: Sheng
  fullname: Sheng, Jipo
– sequence: 7
  givenname: Lifan
  surname: Liang
  fullname: Liang, Lifan
– sequence: 8
  givenname: Jiqiu
  surname: Chen
  fullname: Chen, Jiqiu
– sequence: 9
  givenname: Purushothaman
  surname: K-Raman
  fullname: K-Raman, Purushothaman
– sequence: 10
  givenname: Roger J.
  surname: Hajjar
  fullname: Hajjar, Roger J.
– sequence: 11
  givenname: Djamel
  surname: Lebeche
  fullname: Lebeche, Djamel
  email: Djamel.lebeche@mssm.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21549710$$D View this record in MEDLINE/PubMed
BookMark eNqFktFrFDEQxoNU7LX6Fwhybz7tOskme1nEQinaCgc-qM8hl8ydOXeTM9ld3P_erFeLFuSewjDf75sw31yQMx88EvKSQkmB1m_25bTvjCkZUFoCLwHqJ2RBoRGFFJKfkQUAYwWTTJ6Ti5T2ANDwqnpGzhkVvFlRWBC1Dn5X9Bi7pfPL0Y1hGTG51OcqjBjx5yHXyQWf-3YwmJbdFIyO1ul2aae0Hbzp57b2NqNdsNg6v5vdou7Tc_J0q9uEL-7fS_L1w_svN3fF-tPtx5vrdWEEg76o6k3N0HK7RQGaS2u4oBtbiYaZBuqV3ViUdVPpSspGrHgtLV1JqXkNAg2tq0tydfQ9DJsOrUHfR92qQ3SdjpMK2ql_O959U7swqooyLhrIBq_vDWL4MWDqVeeSwbbVHsOQlFxxYACcZeWrv0c9zPiz1CyojgITQ0oRtw8SCmqOTu3V7-jUHJ0CrnJ0mWoeUcb1el5t_q9rT7DvjizmFY8Oo0rGoTdoXUTTKxvcCf7qEW9yiM7o9jtOmPZhiD6np6hKTIH6PB_WfFeUQrasRDZ4-3-Dk-N_ASqi4LY
CitedBy_id crossref_primary_10_1161_JAHA_122_027621
crossref_primary_10_1093_cvr_cvac093
crossref_primary_10_4103_jpcs_jpcs_19_23
crossref_primary_10_1007_s11926_013_0336_0
crossref_primary_10_1152_ajpheart_00603_2021
crossref_primary_10_3904_kjim_2016_229
crossref_primary_10_1113_JP282728
crossref_primary_10_3390_ijms21041509
crossref_primary_10_1111_eci_12942
crossref_primary_10_3389_fphys_2022_1036945
crossref_primary_10_1136_heartjnl_2012_302970
crossref_primary_10_3923_ijp_2017_212_217
crossref_primary_10_1016_j_cca_2020_11_010
crossref_primary_10_1186_s13098_017_0219_z
crossref_primary_10_1016_j_lfs_2012_10_011
crossref_primary_10_1152_ajplung_00279_2013
crossref_primary_10_1155_2022_3040521
crossref_primary_10_1093_cvr_cvac046
crossref_primary_10_1152_japplphysiol_00785_2012
crossref_primary_10_1093_eurjhf_hfs111
crossref_primary_10_1186_s12872_019_01319_w
crossref_primary_10_1007_s10753_022_01669_2
crossref_primary_10_1111_j_1749_6632_2012_06520_x
crossref_primary_10_1002_adbi_202300211
crossref_primary_10_1093_cvr_cvab234
crossref_primary_10_1042_CS20190578
crossref_primary_10_1210_en_2013_1399
crossref_primary_10_1042_BSR20150139
crossref_primary_10_1139_y2012_053
crossref_primary_10_1002_ehf2_14064
crossref_primary_10_1016_j_tcm_2012_01_004
crossref_primary_10_1111_j_1476_5381_2011_01606_x
crossref_primary_10_4070_kcj_2017_0041
crossref_primary_10_3923_ijp_2019_311_317
crossref_primary_10_1111_sji_12464
crossref_primary_10_1016_j_echo_2013_04_016
crossref_primary_10_1155_2020_8873152
crossref_primary_10_3389_fcell_2021_777258
crossref_primary_10_3390_ijms252111695
crossref_primary_10_3892_br_2016_593
crossref_primary_10_1038_s41598_020_73864_w
crossref_primary_10_1111_tri_12728
crossref_primary_10_1111_1440_1681_12604
crossref_primary_10_1186_s12964_024_01842_0
crossref_primary_10_3892_br_2016_749
crossref_primary_10_3390_cells12070999
crossref_primary_10_1016_j_phrs_2022_106257
crossref_primary_10_1152_ajpendo_00202_2020
crossref_primary_10_1016_j_mce_2013_06_028
crossref_primary_10_1016_j_freeradbiomed_2012_10_555
crossref_primary_10_1177_1087057112456878
crossref_primary_10_4155_fmc_14_147
crossref_primary_10_1590_1678_4324_2017160333
crossref_primary_10_3390_diagnostics14232677
crossref_primary_10_1016_j_cyto_2018_01_002
crossref_primary_10_3389_fphys_2018_01799
crossref_primary_10_1074_jbc_M115_702688
crossref_primary_10_1113_jphysiol_2013_258731
crossref_primary_10_1016_j_ijcard_2015_05_184
crossref_primary_10_1038_s41598_018_34112_4
crossref_primary_10_1161_CIRCHEARTFAILURE_112_967489
crossref_primary_10_1016_j_reprotox_2014_09_013
crossref_primary_10_1016_j_phrs_2020_105414
Cites_doi 10.1161/01.RES.0000099504.30207.F5
10.1152/ajpcell.2001.280.1.C53
10.1016/j.bbrc.2008.03.100
10.1371/journal.pone.0000031
10.1016/j.bbrc.2006.08.052
10.1152/ajpheart.00361.2007
10.1586/erc.10.17
10.1371/journal.pone.0006743
10.1038/onc.2008.308
10.1038/nprot.2008.138
10.1210/en.2006-0728
10.1016/j.yjmcc.2010.12.018
10.1007/s00395-007-0673-0
10.1152/ajpheart.00431.2009
10.1371/journal.pone.0006474
10.1210/en.2004-0985
10.1161/01.CIR.0000084503.91330.49
10.1038/35053000
10.1016/j.yjmcc.2010.04.010
10.1016/j.echo.2005.10.005
10.1002/ccd.1810070304
10.1161/01.RES.0000187457.24338.3D
10.1016/j.bbrc.2005.06.202
10.1152/ajpheart.00157.2009
10.1016/j.tcm.2007.09.005
10.1161/CIRCULATIONAHA.108.783852
10.1091/mbc.E08-06-0587
10.1007/s10495-008-0302-x
10.1016/j.atherosclerosis.2005.02.014
10.4049/jimmunol.174.9.5789
10.1007/s11892-008-0042-x
10.1007/s11010-009-0219-x
10.1016/j.jacc.2008.07.073
10.1016/j.jmb.2006.10.057
10.1006/jmcc.2002.1526
10.1002/biof.63
10.1016/j.yjmcc.2007.08.009
10.1016/S0735-1097(03)00471-6
10.1016/j.yjmcc.2008.05.006
10.1007/s00125-006-0229-0
10.1016/j.cardiores.2006.03.016
10.1177/153537020523001012
10.1172/JCI20785
10.1152/ajpheart.00313.2002
ContentType Journal Article
Copyright 2011 Elsevier Ltd
Elsevier Ltd
Copyright © 2011 Elsevier Ltd. All rights reserved.
2011 Elsevier Ltd. All rights reserved. 2011
Copyright_xml – notice: 2011 Elsevier Ltd
– notice: Elsevier Ltd
– notice: Copyright © 2011 Elsevier Ltd. All rights reserved.
– notice: 2011 Elsevier Ltd. All rights reserved. 2011
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.yjmcc.2011.04.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList


MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1095-8584
EndPage 155
ExternalDocumentID PMC3124590
21549710
10_1016_j_yjmcc_2011_04_006
S0022282811001635
1_s2_0_S0022282811001635
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: K01 HL076659
– fundername: NHLBI NIH HHS
  grantid: T32 HL007824
– fundername: NHLBI NIH HHS
  grantid: K01 HL103176
– fundername: National Heart, Lung, and Blood Institute : NHLBI
  grantid: K01 HL076659-05 || HL
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29L
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLJU
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
ADUVX
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HLW
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
LX2
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SBG
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
WUQ
X7M
XPP
Z5R
ZGI
ZMT
ZU3
~G-
AACTN
AEHWI
AFCTW
AFKWA
AJOXV
AMFUW
RIG
SSU
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
ACLOT
CITATION
~HD
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c520t-36b62ed4dfe50a48dc451bd3592c9067dbde8693a388957468d1788a4605ec163
IEDL.DBID .~1
ISSN 0022-2828
1095-8584
IngestDate Tue Sep 30 16:35:42 EDT 2025
Sun Sep 28 07:58:22 EDT 2025
Mon Jul 21 06:06:40 EDT 2025
Wed Oct 01 04:42:28 EDT 2025
Thu Apr 24 23:05:25 EDT 2025
Fri Feb 23 02:33:01 EST 2024
Sun Feb 23 10:19:50 EST 2025
Tue Aug 26 16:48:49 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Adeno-associated virus 9
Oxidative stress
Fibrosis
Diabetic cardiomyopathy
Cardiac remodeling
Hemodynamics
Resistin
Apoptosis
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2011 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c520t-36b62ed4dfe50a48dc451bd3592c9067dbde8693a388957468d1788a4605ec163
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ERC and LH contributed equally to this work.
Current address: Mitochondria and Metabolism Center, University of Washington, Box 358057 Seattle, WA 98109-4714
PMID 21549710
PQID 874020042
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3124590
proquest_miscellaneous_874020042
pubmed_primary_21549710
crossref_primary_10_1016_j_yjmcc_2011_04_006
crossref_citationtrail_10_1016_j_yjmcc_2011_04_006
elsevier_sciencedirect_doi_10_1016_j_yjmcc_2011_04_006
elsevier_clinicalkeyesjournals_1_s2_0_S0022282811001635
elsevier_clinicalkey_doi_10_1016_j_yjmcc_2011_04_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-08-01
PublicationDateYYYYMMDD 2011-08-01
PublicationDate_xml – month: 08
  year: 2011
  text: 2011-08-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of molecular and cellular cardiology
PublicationTitleAlternate J Mol Cell Cardiol
PublicationYear 2011
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Yoon, Lee, Cha, Jeong, Kim, Jang (bb0165) 2010; 49
Kim, Oh, Sakata, Liang, Park, Hajjar (bb0045) 2008; 45
Gualillo, Gonzalez-Juanatey, Lago (bb0025) 2007; 17
Dobrin, Lebeche (bb0140) 2010; 8
Lang, Bierig, Devereux, Flachskampf, Foster, Pellikka (bb0055) 2005; 18
Bokarewa, Nagaev, Dahlberg, Smith, Tarkowski (bb0115) 2005; 174
Westermann, Van Linthout, Dhayat, Dhayat, Schmidt, Noutsias (bb0170) 2007; 102
Cucoranu, Clempus, Dikalova, Phelan, Ariyan, Dikalov (bb0130) 2005; 97
Panek, Posch, Alenina, Ghadge, Erdmann, Popova (bb0155) 2009; 4
Karakikes, Kim, Hadri, Sakata, Sun, Zhang (bb0020) 2009; 4
Gueret, Meerbaum, Zwehl, Wyatt, Davidson, Uchiyama (bb0060) 1981; 7
Harmancey, Taegtmeyer (bb0145) 2008; 8
Choi, Zhong, Hoit, Grupp, Hahn, Dilly (bb0180) 2002; 283
Vafiadaki, Sanoudou, Arvanitis, Catino, Kranias, Kontrogianni-Konstantopoulos (bb0190) 2007; 367
Verma, Li, Wang, Fedak, Li, Weisel (bb0210) 2003; 108
Gao, Chang Chua, Chen, Wang, Xu, Hamdy (bb0030) 2007; 43
Frankel, Vasan, D'Agostino, Benjamin, Levy, Wang (bb0040) 2009; 53
Byrne, Grieve, Bendall, Li, Gove, Lambeth (bb0105) 2003; 93
Sato, Kobayashi, Inoguchi, Sonoda, Imamura, Sekiguchi (bb0075) 2005; 146
Heymes, Bendall, Ratajczak, Cave, Samuel, Hasenfuss (bb0110) 2003; 41
Pacher, Nagayama, Mukhopadhyay, Batkai, Kass (bb0065) 2008; 3
Steppan, Bailey, Bhat, Brown, Banerjee, Wright (bb0005) 2001; 409
Wang, Hung, Chang, Kuan, Shyu (bb0015) 2007; 293
Vandecaetsbeek, Raeymaekers, Wuytack, Vangheluwe (bb0085) 2009; 35
Saha, Xia, Grondin, Engle, Jakubowski (bb0070) 2005; 230
Siwik, Pagano, Colucci (bb0135) 2001; 280
Hayata, Fujio, Yamamoto, Iwakura, Obana, Takai (bb0150) 2008; 370
Suckau, Fechner, Chemaly, Krohn, Hadri, Kockskamper (bb0050) 2009; 119
Vafiadaki, Arvanitis, Pagakis, Papalouka, Sanoudou, Kontrogianni-Konstantopoulos (bb0185) 2009; 20
Burnett, Lee, Kinnaird, Stabile, Durrani, Dullum (bb0010) 2005; 182
Chen, Jiang, Lu, Chai, Wang, Lin (bb0205) 2010; 299
Li, Yang, Ceylan-Isik, Du, Sreejayan, Ren (bb0220) 2006; 49
Umar, van der Laarse (bb0215) 2010; 333
Pinton, Giorgi, Siviero, Zecchini, Rizzuto (bb0195) 2008; 27
Ares-Carrasco, Picatoste, Benito-Martin, Zubiri, Sanz, Sanchez-Nino (bb0175) 2009; 297
Rothwell, Richards, Pemberton (bb0035) 2006; 349
Aragno, Mastrocola, Medana, Catalano, Vercellinatto, Danni (bb0160) 2006; 147
Satoh, Nguyen, Miles, Imamura, Usui, Olefsky (bb0080) 2004; 114
Murdoch, Zhang, Cave, Shah (bb0100) 2006; 71
Nagaev, Bokarewa, Tarkowski, Smith (bb0120) 2006; 1
Maejima, Kuroda, Matsushima, Ago, Sadoshima (bb0090) 2011; 50
Sawyer, Siwik, Xiao, Pimentel, Singh, Colucci (bb0095) 2002; 34
Silswal, Singh, Aruna, Mukhopadhyay, Ghosh, Ehtesham (bb0125) 2005; 334
Lee, Gustafsson (bb0200) 2009; 14
Gualillo (10.1016/j.yjmcc.2011.04.006_bb0025) 2007; 17
Bokarewa (10.1016/j.yjmcc.2011.04.006_bb0115) 2005; 174
Aragno (10.1016/j.yjmcc.2011.04.006_bb0160) 2006; 147
Ares-Carrasco (10.1016/j.yjmcc.2011.04.006_bb0175) 2009; 297
Vafiadaki (10.1016/j.yjmcc.2011.04.006_bb0185) 2009; 20
Burnett (10.1016/j.yjmcc.2011.04.006_bb0010) 2005; 182
Karakikes (10.1016/j.yjmcc.2011.04.006_bb0020) 2009; 4
Wang (10.1016/j.yjmcc.2011.04.006_bb0015) 2007; 293
Harmancey (10.1016/j.yjmcc.2011.04.006_bb0145) 2008; 8
Sawyer (10.1016/j.yjmcc.2011.04.006_bb0095) 2002; 34
Siwik (10.1016/j.yjmcc.2011.04.006_bb0135) 2001; 280
Gao (10.1016/j.yjmcc.2011.04.006_bb0030) 2007; 43
Rothwell (10.1016/j.yjmcc.2011.04.006_bb0035) 2006; 349
Byrne (10.1016/j.yjmcc.2011.04.006_bb0105) 2003; 93
Vandecaetsbeek (10.1016/j.yjmcc.2011.04.006_bb0085) 2009; 35
Maejima (10.1016/j.yjmcc.2011.04.006_bb0090) 2011; 50
Hayata (10.1016/j.yjmcc.2011.04.006_bb0150) 2008; 370
Westermann (10.1016/j.yjmcc.2011.04.006_bb0170) 2007; 102
Pinton (10.1016/j.yjmcc.2011.04.006_bb0195) 2008; 27
Gueret (10.1016/j.yjmcc.2011.04.006_bb0060) 1981; 7
Li (10.1016/j.yjmcc.2011.04.006_bb0220) 2006; 49
Panek (10.1016/j.yjmcc.2011.04.006_bb0155) 2009; 4
Yoon (10.1016/j.yjmcc.2011.04.006_bb0165) 2010; 49
Saha (10.1016/j.yjmcc.2011.04.006_bb0070) 2005; 230
Sato (10.1016/j.yjmcc.2011.04.006_bb0075) 2005; 146
Cucoranu (10.1016/j.yjmcc.2011.04.006_bb0130) 2005; 97
Pacher (10.1016/j.yjmcc.2011.04.006_bb0065) 2008; 3
Kim (10.1016/j.yjmcc.2011.04.006_bb0045) 2008; 45
Murdoch (10.1016/j.yjmcc.2011.04.006_bb0100) 2006; 71
Silswal (10.1016/j.yjmcc.2011.04.006_bb0125) 2005; 334
Suckau (10.1016/j.yjmcc.2011.04.006_bb0050) 2009; 119
Frankel (10.1016/j.yjmcc.2011.04.006_bb0040) 2009; 53
Dobrin (10.1016/j.yjmcc.2011.04.006_bb0140) 2010; 8
Lee (10.1016/j.yjmcc.2011.04.006_bb0200) 2009; 14
Vafiadaki (10.1016/j.yjmcc.2011.04.006_bb0190) 2007; 367
Verma (10.1016/j.yjmcc.2011.04.006_bb0210) 2003; 108
Heymes (10.1016/j.yjmcc.2011.04.006_bb0110) 2003; 41
Chen (10.1016/j.yjmcc.2011.04.006_bb0205) 2010; 299
Steppan (10.1016/j.yjmcc.2011.04.006_bb0005) 2001; 409
Nagaev (10.1016/j.yjmcc.2011.04.006_bb0120) 2006; 1
Lang (10.1016/j.yjmcc.2011.04.006_bb0055) 2005; 18
Satoh (10.1016/j.yjmcc.2011.04.006_bb0080) 2004; 114
Choi (10.1016/j.yjmcc.2011.04.006_bb0180) 2002; 283
Umar (10.1016/j.yjmcc.2011.04.006_bb0215) 2010; 333
References_xml – volume: 114
  start-page: 224
  year: 2004
  end-page: 231
  ident: bb0080
  article-title: Adenovirus-mediated chronic “hyper-resistinemia” leads to
  publication-title: J Clin Invest
– volume: 27
  start-page: 6407
  year: 2008
  end-page: 6418
  ident: bb0195
  article-title: Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
  publication-title: Oncogene
– volume: 14
  start-page: 536
  year: 2009
  end-page: 548
  ident: bb0200
  article-title: Role of apoptosis in cardiovascular disease
  publication-title: Apoptosis
– volume: 34
  start-page: 379
  year: 2002
  end-page: 388
  ident: bb0095
  article-title: Role of oxidative stress in myocardial hypertrophy and failure
  publication-title: J Mol Cell Cardiol
– volume: 45
  start-page: 270
  year: 2008
  end-page: 280
  ident: bb0045
  article-title: Role of resistin in cardiac contractility and hypertrophy
  publication-title: J Mol Cell Cardiol
– volume: 49
  start-page: 294
  year: 2010
  end-page: 303
  ident: bb0165
  article-title: The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis
  publication-title: J Mol Cell Cardiol
– volume: 50
  start-page: 408
  year: 2011
  end-page: 416
  ident: bb0090
  article-title: Regulation of myocardial growth and death by NADPH oxidase
  publication-title: J Mol Cell Cardiol
– volume: 93
  start-page: 802
  year: 2003
  end-page: 805
  ident: bb0105
  article-title: Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy
  publication-title: Circ Res
– volume: 1
  start-page: e31
  year: 2006
  ident: bb0120
  article-title: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes
  publication-title: PLoS One
– volume: 280
  start-page: C53
  year: 2001
  end-page: C60
  ident: bb0135
  article-title: Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts
  publication-title: Am J Physiol
– volume: 119
  start-page: 1241
  year: 2009
  end-page: 1252
  ident: bb0050
  article-title: Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy
  publication-title: Circulation
– volume: 174
  start-page: 5789
  year: 2005
  end-page: 5795
  ident: bb0115
  article-title: Resistin, an adipokine with potent proinflammatory properties
  publication-title: J Immunol
– volume: 293
  start-page: H2305
  year: 2007
  end-page: H2312
  ident: bb0015
  article-title: Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 35
  start-page: 484
  year: 2009
  end-page: 499
  ident: bb0085
  article-title: Factors controlling the activity of the SERCA2a pump in the normal and failing heart
  publication-title: Biofactors
– volume: 409
  start-page: 307
  year: 2001
  end-page: 312
  ident: bb0005
  article-title: The hormone resistin links obesity to diabetes
  publication-title: Nature
– volume: 334
  start-page: 1092
  year: 2005
  end-page: 1101
  ident: bb0125
  article-title: Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway
  publication-title: Biochem Biophys Res Commun
– volume: 349
  start-page: 400
  year: 2006
  end-page: 407
  ident: bb0035
  article-title: Resistin worsens cardiac ischaemia–reperfusion injury
  publication-title: Biochem Biophys Res Commun
– volume: 8
  start-page: 373
  year: 2010
  end-page: 391
  ident: bb0140
  article-title: Diabetic cardiomyopathy: signaling defects and therapeutic approaches
  publication-title: Expert Rev Cardiovasc Ther
– volume: 299
  start-page: H193
  year: 2010
  end-page: H201
  ident: bb0205
  article-title: Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 53
  start-page: 754
  year: 2009
  end-page: 762
  ident: bb0040
  article-title: Resistin, adiponectin, and risk of heart failure the Framingham offspring study
  publication-title: J Am Coll Cardiol
– volume: 97
  start-page: 900
  year: 2005
  end-page: 907
  ident: bb0130
  article-title: NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts
  publication-title: Circ Res
– volume: 71
  start-page: 208
  year: 2006
  end-page: 215
  ident: bb0100
  article-title: NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
  publication-title: Cardiovasc Res
– volume: 18
  start-page: 1440
  year: 2005
  end-page: 1463
  ident: bb0055
  article-title: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
  publication-title: J Am Soc Echocardiogr
– volume: 230
  start-page: 777
  year: 2005
  end-page: 784
  ident: bb0070
  article-title: Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models
  publication-title: Exp Biol Med
– volume: 333
  start-page: 191
  year: 2010
  end-page: 201
  ident: bb0215
  article-title: Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart
  publication-title: Mol Cell Biochem
– volume: 49
  start-page: 1434
  year: 2006
  end-page: 1446
  ident: bb0220
  article-title: Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+−ATPase and myosin heavy chain isozyme switch
  publication-title: Diabetologia
– volume: 4
  start-page: e6743
  year: 2009
  ident: bb0155
  article-title: Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload
  publication-title: PLoS One
– volume: 297
  start-page: H2109
  year: 2009
  end-page: H2119
  ident: bb0175
  article-title: Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 108
  start-page: 736
  year: 2003
  end-page: 740
  ident: bb0210
  article-title: Resistin promotes endothelial cell activation: further evidence of adipokine–endothelial interaction
  publication-title: Circulation
– volume: 370
  start-page: 274
  year: 2008
  end-page: 278
  ident: bb0150
  article-title: Connective tissue growth factor induces cardiac hypertrophy through Akt signaling
  publication-title: Biochem Biophys Res Commun
– volume: 367
  start-page: 65
  year: 2007
  end-page: 79
  ident: bb0190
  article-title: Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function
  publication-title: J Mol Biol
– volume: 7
  start-page: 247
  year: 1981
  end-page: 258
  ident: bb0060
  article-title: Two-dimensional echocardiographic assessment of left ventricular stroke volume: experimental correlation with thermodilution and cineangiography in normal and ischemic states
  publication-title: Cathet Cardiovasc Diagn
– volume: 3
  start-page: 1422
  year: 2008
  end-page: 1434
  ident: bb0065
  article-title: Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats
  publication-title: Nat Protoc
– volume: 283
  start-page: H1398
  year: 2002
  end-page: H1408
  ident: bb0180
  article-title: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 182
  start-page: 241
  year: 2005
  end-page: 248
  ident: bb0010
  article-title: The potential role of resistin in atherogenesis
  publication-title: Atherosclerosis
– volume: 102
  start-page: 500
  year: 2007
  end-page: 507
  ident: bb0170
  article-title: Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy
  publication-title: Basic Res Cardiol
– volume: 20
  start-page: 306
  year: 2009
  end-page: 318
  ident: bb0185
  article-title: The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival
  publication-title: Mol Biol Cell
– volume: 43
  start-page: 601
  year: 2007
  end-page: 609
  ident: bb0030
  article-title: Resistin, an adipocytokine, offers protection against acute myocardial infarction
  publication-title: J Mol Cell Cardiol
– volume: 147
  start-page: 5967
  year: 2006
  end-page: 5974
  ident: bb0160
  article-title: Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes
  publication-title: Endocrinology
– volume: 41
  start-page: 2164
  year: 2003
  end-page: 2171
  ident: bb0110
  article-title: Increased myocardial NADPH oxidase activity in human heart failure
  publication-title: J Am Coll Cardiol
– volume: 4
  start-page: e6474
  year: 2009
  ident: bb0020
  article-title: Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a
  publication-title: PLoS One
– volume: 17
  start-page: 275
  year: 2007
  end-page: 283
  ident: bb0025
  article-title: The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives
  publication-title: Trends Cardiovasc Med
– volume: 146
  start-page: 273
  year: 2005
  end-page: 279
  ident: bb0075
  article-title: Adenovirus-mediated high expression of resistin causes dyslipidemia in mice
  publication-title: Endocrinology
– volume: 8
  start-page: 243
  year: 2008
  end-page: 248
  ident: bb0145
  article-title: The complexities of diabetic cardiomyopathy: lessons from patients and animal models
  publication-title: Curr Diab Rep
– volume: 93
  start-page: 802
  issue: 9
  year: 2003
  ident: 10.1016/j.yjmcc.2011.04.006_bb0105
  article-title: Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000099504.30207.F5
– volume: 280
  start-page: C53
  issue: 1
  year: 2001
  ident: 10.1016/j.yjmcc.2011.04.006_bb0135
  article-title: Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts
  publication-title: Am J Physiol
  doi: 10.1152/ajpcell.2001.280.1.C53
– volume: 370
  start-page: 274
  issue: 2
  year: 2008
  ident: 10.1016/j.yjmcc.2011.04.006_bb0150
  article-title: Connective tissue growth factor induces cardiac hypertrophy through Akt signaling
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2008.03.100
– volume: 1
  start-page: e31
  year: 2006
  ident: 10.1016/j.yjmcc.2011.04.006_bb0120
  article-title: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0000031
– volume: 349
  start-page: 400
  issue: 1
  year: 2006
  ident: 10.1016/j.yjmcc.2011.04.006_bb0035
  article-title: Resistin worsens cardiac ischaemia–reperfusion injury
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.08.052
– volume: 293
  start-page: H2305
  issue: 4
  year: 2007
  ident: 10.1016/j.yjmcc.2011.04.006_bb0015
  article-title: Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-alpha
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00361.2007
– volume: 8
  start-page: 373
  issue: 3
  year: 2010
  ident: 10.1016/j.yjmcc.2011.04.006_bb0140
  article-title: Diabetic cardiomyopathy: signaling defects and therapeutic approaches
  publication-title: Expert Rev Cardiovasc Ther
  doi: 10.1586/erc.10.17
– volume: 4
  start-page: e6743
  issue: 8
  year: 2009
  ident: 10.1016/j.yjmcc.2011.04.006_bb0155
  article-title: Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006743
– volume: 27
  start-page: 6407
  issue: 50
  year: 2008
  ident: 10.1016/j.yjmcc.2011.04.006_bb0195
  article-title: Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
  publication-title: Oncogene
  doi: 10.1038/onc.2008.308
– volume: 3
  start-page: 1422
  issue: 9
  year: 2008
  ident: 10.1016/j.yjmcc.2011.04.006_bb0065
  article-title: Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2008.138
– volume: 147
  start-page: 5967
  issue: 12
  year: 2006
  ident: 10.1016/j.yjmcc.2011.04.006_bb0160
  article-title: Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes
  publication-title: Endocrinology
  doi: 10.1210/en.2006-0728
– volume: 50
  start-page: 408
  issue: 3
  year: 2011
  ident: 10.1016/j.yjmcc.2011.04.006_bb0090
  article-title: Regulation of myocardial growth and death by NADPH oxidase
  publication-title: J Mol Cell Cardiol
  doi: 10.1016/j.yjmcc.2010.12.018
– volume: 102
  start-page: 500
  issue: 6
  year: 2007
  ident: 10.1016/j.yjmcc.2011.04.006_bb0170
  article-title: Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-007-0673-0
– volume: 299
  start-page: H193
  issue: 1
  year: 2010
  ident: 10.1016/j.yjmcc.2011.04.006_bb0205
  article-title: Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00431.2009
– volume: 4
  start-page: e6474
  issue: 7
  year: 2009
  ident: 10.1016/j.yjmcc.2011.04.006_bb0020
  article-title: Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006474
– volume: 146
  start-page: 273
  issue: 1
  year: 2005
  ident: 10.1016/j.yjmcc.2011.04.006_bb0075
  article-title: Adenovirus-mediated high expression of resistin causes dyslipidemia in mice
  publication-title: Endocrinology
  doi: 10.1210/en.2004-0985
– volume: 108
  start-page: 736
  issue: 6
  year: 2003
  ident: 10.1016/j.yjmcc.2011.04.006_bb0210
  article-title: Resistin promotes endothelial cell activation: further evidence of adipokine–endothelial interaction
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000084503.91330.49
– volume: 409
  start-page: 307
  issue: 6818
  year: 2001
  ident: 10.1016/j.yjmcc.2011.04.006_bb0005
  article-title: The hormone resistin links obesity to diabetes
  publication-title: Nature
  doi: 10.1038/35053000
– volume: 49
  start-page: 294
  issue: 2
  year: 2010
  ident: 10.1016/j.yjmcc.2011.04.006_bb0165
  article-title: The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis
  publication-title: J Mol Cell Cardiol
  doi: 10.1016/j.yjmcc.2010.04.010
– volume: 18
  start-page: 1440
  issue: 12
  year: 2005
  ident: 10.1016/j.yjmcc.2011.04.006_bb0055
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2005.10.005
– volume: 7
  start-page: 247
  issue: 3
  year: 1981
  ident: 10.1016/j.yjmcc.2011.04.006_bb0060
  article-title: Two-dimensional echocardiographic assessment of left ventricular stroke volume: experimental correlation with thermodilution and cineangiography in normal and ischemic states
  publication-title: Cathet Cardiovasc Diagn
  doi: 10.1002/ccd.1810070304
– volume: 97
  start-page: 900
  issue: 9
  year: 2005
  ident: 10.1016/j.yjmcc.2011.04.006_bb0130
  article-title: NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000187457.24338.3D
– volume: 334
  start-page: 1092
  issue: 4
  year: 2005
  ident: 10.1016/j.yjmcc.2011.04.006_bb0125
  article-title: Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2005.06.202
– volume: 297
  start-page: H2109
  issue: 6
  year: 2009
  ident: 10.1016/j.yjmcc.2011.04.006_bb0175
  article-title: Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00157.2009
– volume: 17
  start-page: 275
  issue: 8
  year: 2007
  ident: 10.1016/j.yjmcc.2011.04.006_bb0025
  article-title: The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives
  publication-title: Trends Cardiovasc Med
  doi: 10.1016/j.tcm.2007.09.005
– volume: 119
  start-page: 1241
  issue: 9
  year: 2009
  ident: 10.1016/j.yjmcc.2011.04.006_bb0050
  article-title: Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.783852
– volume: 20
  start-page: 306
  issue: 1
  year: 2009
  ident: 10.1016/j.yjmcc.2011.04.006_bb0185
  article-title: The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.E08-06-0587
– volume: 14
  start-page: 536
  issue: 4
  year: 2009
  ident: 10.1016/j.yjmcc.2011.04.006_bb0200
  article-title: Role of apoptosis in cardiovascular disease
  publication-title: Apoptosis
  doi: 10.1007/s10495-008-0302-x
– volume: 182
  start-page: 241
  issue: 2
  year: 2005
  ident: 10.1016/j.yjmcc.2011.04.006_bb0010
  article-title: The potential role of resistin in atherogenesis
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2005.02.014
– volume: 174
  start-page: 5789
  issue: 9
  year: 2005
  ident: 10.1016/j.yjmcc.2011.04.006_bb0115
  article-title: Resistin, an adipokine with potent proinflammatory properties
  publication-title: J Immunol
  doi: 10.4049/jimmunol.174.9.5789
– volume: 8
  start-page: 243
  issue: 3
  year: 2008
  ident: 10.1016/j.yjmcc.2011.04.006_bb0145
  article-title: The complexities of diabetic cardiomyopathy: lessons from patients and animal models
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-008-0042-x
– volume: 333
  start-page: 191
  issue: 1–2
  year: 2010
  ident: 10.1016/j.yjmcc.2011.04.006_bb0215
  article-title: Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-009-0219-x
– volume: 53
  start-page: 754
  issue: 9
  year: 2009
  ident: 10.1016/j.yjmcc.2011.04.006_bb0040
  article-title: Resistin, adiponectin, and risk of heart failure the Framingham offspring study
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.07.073
– volume: 367
  start-page: 65
  issue: 1
  year: 2007
  ident: 10.1016/j.yjmcc.2011.04.006_bb0190
  article-title: Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function
  publication-title: J Mol Biol
  doi: 10.1016/j.jmb.2006.10.057
– volume: 34
  start-page: 379
  issue: 4
  year: 2002
  ident: 10.1016/j.yjmcc.2011.04.006_bb0095
  article-title: Role of oxidative stress in myocardial hypertrophy and failure
  publication-title: J Mol Cell Cardiol
  doi: 10.1006/jmcc.2002.1526
– volume: 35
  start-page: 484
  issue: 6
  year: 2009
  ident: 10.1016/j.yjmcc.2011.04.006_bb0085
  article-title: Factors controlling the activity of the SERCA2a pump in the normal and failing heart
  publication-title: Biofactors
  doi: 10.1002/biof.63
– volume: 43
  start-page: 601
  issue: 5
  year: 2007
  ident: 10.1016/j.yjmcc.2011.04.006_bb0030
  article-title: Resistin, an adipocytokine, offers protection against acute myocardial infarction
  publication-title: J Mol Cell Cardiol
  doi: 10.1016/j.yjmcc.2007.08.009
– volume: 41
  start-page: 2164
  issue: 12
  year: 2003
  ident: 10.1016/j.yjmcc.2011.04.006_bb0110
  article-title: Increased myocardial NADPH oxidase activity in human heart failure
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(03)00471-6
– volume: 45
  start-page: 270
  issue: 2
  year: 2008
  ident: 10.1016/j.yjmcc.2011.04.006_bb0045
  article-title: Role of resistin in cardiac contractility and hypertrophy
  publication-title: J Mol Cell Cardiol
  doi: 10.1016/j.yjmcc.2008.05.006
– volume: 49
  start-page: 1434
  issue: 6
  year: 2006
  ident: 10.1016/j.yjmcc.2011.04.006_bb0220
  article-title: Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+−ATPase and myosin heavy chain isozyme switch
  publication-title: Diabetologia
  doi: 10.1007/s00125-006-0229-0
– volume: 71
  start-page: 208
  issue: 2
  year: 2006
  ident: 10.1016/j.yjmcc.2011.04.006_bb0100
  article-title: NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2006.03.016
– volume: 230
  start-page: 777
  issue: 10
  year: 2005
  ident: 10.1016/j.yjmcc.2011.04.006_bb0070
  article-title: Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models
  publication-title: Exp Biol Med
  doi: 10.1177/153537020523001012
– volume: 114
  start-page: 224
  issue: 2
  year: 2004
  ident: 10.1016/j.yjmcc.2011.04.006_bb0080
  article-title: Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats
  publication-title: J Clin Invest
  doi: 10.1172/JCI20785
– volume: 283
  start-page: H1398
  issue: 4
  year: 2002
  ident: 10.1016/j.yjmcc.2011.04.006_bb0180
  article-title: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00313.2002
SSID ssj0009433
Score 2.3191636
Snippet We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular...
Abstract We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 144
SubjectTerms Adeno-associated virus 9
Animals
Apoptosis
Apoptosis - genetics
Biomarkers - metabolism
Blood Glucose - genetics
Cardiac remodeling
Cardiovascular
Cells, Cultured
Diabetic cardiomyopathy
Fibrosis
Fibrosis - genetics
Gene Expression - genetics
Gene Expression Regulation
Heart - physiopathology
Heart Ventricles - metabolism
Heart Ventricles - pathology
Heart Ventricles - physiopathology
Hemodynamics
Hemodynamics - genetics
Hypertrophy, Left Ventricular - genetics
Hypertrophy, Left Ventricular - metabolism
Hypertrophy, Left Ventricular - pathology
Inflammation Mediators - metabolism
Male
Myocardium - enzymology
Myocardium - metabolism
Myocardium - pathology
Myocytes, Cardiac - enzymology
Myocytes, Cardiac - metabolism
Myocytes, Cardiac - pathology
Nitric Oxide Synthase - genetics
Nitric Oxide Synthase - metabolism
Oxidative stress
Oxidative Stress - genetics
Rats
Rats, Sprague-Dawley
Resistin
Resistin - genetics
Resistin - metabolism
Ventricular Remodeling - genetics
Title Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0022282811001635
https://www.clinicalkey.es/playcontent/1-s2.0-S0022282811001635
https://dx.doi.org/10.1016/j.yjmcc.2011.04.006
https://www.ncbi.nlm.nih.gov/pubmed/21549710
https://www.proquest.com/docview/874020042
https://pubmed.ncbi.nlm.nih.gov/PMC3124590
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1095-8584
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009433
  issn: 0022-2828
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1095-8584
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009433
  issn: 0022-2828
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1095-8584
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009433
  issn: 0022-2828
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1095-8584
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009433
  issn: 0022-2828
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1095-8584
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009433
  issn: 0022-2828
  databaseCode: AKRWK
  dateStart: 19700301
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8hJqG9TPtex0B-2OMyEsdxnUeEhrp18ICGxpvl2O4WBC4iBdEX_nbuEqfQsTEJqVLU5i51fOe7s33-HcDHiZPSmlImGAupROR8khiPX9F5p6qiGYmlpYG9fTk6FN-OiqMV2OnPwlBaZbT9nU1vrXX8ZSv25tZZXdMZX1q94IpAzzCqoIPmhP6FOv35-jbNoxRdOXnKWifqHnmozfGaH59aG3E8CUVb_ss73Y8-_0yivOOVdp_DsxhOsu2uxS9gxYeXsLYXN8xfgf4-Db8SMr-sDuyyvpwynF_TuA6Mkjf9VUyEDXjfoZgbdjpH90Zqc8LcvCG_R7JjJjhkbQvnoLejp6HuNK_hcPfLj51REmsqJLbg6SzJZSW5d8JNfJEaoZwVRVa5vCi5LdFzucp5Jcvc5EqVxVBI5TKcJRvaPvUWu_kNrIZp8O-AIaksTeYdEgtnssoOvcqrAj9imFdqALzvS20j4DjVvTjRfWbZsW4FoEkAOhUaBTCATwumsw5v42Fy0QtJ90dJ0fhp9AcPsw3_xuabOIAbnemG61TfU7IByAXnkp7-_y9Zr0MaRzBty5jgpxeNpqKIZKv4AN52KrV4c04AehgDYnuXlG1BQODgy3dC_bsFCc8xcCvK9P1j27sOT_vl8zT7AKuz8wu_gfHXrNpsB9gmPNn-Oh7t03V88HN8AyDZMvI
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTgJeEJ-j48sPPBItcWzXeZwmpo61fdqkvVmJ7UKmzZ1IN9H_fneJUyiDISHlJbEvcXznu7N9_h3Ax7lTypaFStAX0onI-TwpPd6i8U51RTMSS0sD05kan4ovZ_JsCw76szAUVhl1f6fTW20dn-zF3ty7qms640urF1wT6Bl6FfIBbAuJOnkA2_tHx-PZT-xd0WWUp8B1IujBh9owr9X5pbURypOAtNXfDNRdB_T3OMpfDNPhU3gSPUq23zX6GWz58BweTuOe-Qswk0X4mpAGZnVgN_XNguEUm4Z2YBS_6X_EWNiA5Q453bDLFVo4kpwL5lYNmT5iHyuDQ9I2dw4aPHobik_zEk4PP58cjJOYViGxkqfLJFeV4t4JN_cyLYV2VsiscrksuC3QeLnKea2KvMy1LuRIKO0ynCiXtIPqLfb0KxiERfCvgWFVVZSZd1hZuDKr7MjrvJJ4iVFe6SHwvi-NjZjjlPriwvTBZeemZYAhBphUGGTAED6tia46yI37q4ueSaY_TYr6z6BJuJ9s9Ccy38Qx3JjMNNyk5o6cDUGtKTdE9d-fZL0MGRzEtDNTBr-4bgzlRSR1xYew04nU-s85YeihG4jt3RC2dQXCB98sCfW3Fic8R99NFunu_7b3Azwan0wnZnI0O34Dj_vV9DR7C4Pl92v_Dt2xZfU-Drdb0LAz-g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+in+vivo+resistin+overexpression+induces+myocardial+dysfunction+and+remodeling+in+rats&rft.jtitle=Journal+of+molecular+and+cellular+cardiology&rft.au=Chemaly%2C+Elie+R.&rft.au=Hadri%2C+Lahouaria&rft.au=Zhang%2C+Shihong&rft.au=Kim%2C+Maengjo&rft.date=2011-08-01&rft.issn=0022-2828&rft.volume=51&rft.issue=2&rft.spage=144&rft.epage=155&rft_id=info:doi/10.1016%2Fj.yjmcc.2011.04.006&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_yjmcc_2011_04_006
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00222828%2FS0022282811X00081%2Fcov150h.gif